QMETRIC GROUP LIMITED

Comprehensive Financial Health Assessment: QMETRIC GROUP LIMITED

1. Financial Health Score: B+ (Provisional) Explanation: Based on the available vital signs, the patient exhibits a robust structural constitution and excellent regulatory health, indicated by a substantial share capital base and flawless filing compliance. However, the absence of detailed profit & loss and balance sheet metrics (the "blood work") means we cannot fully assess metabolic efficiency (profitability) or circulatory health (cash flow). The score is provisional; the massive capital base suggests resilience, but a definitive A grade requires confirmation of operational profitability.

2. Key Vital Signs

• Regulatory Pulse (Filing Compliance): Strong and steady. The company’s accounts and confirmation statements are up to date with no overdue flags. This indicates a healthy corporate heartbeat and a lack of administrative distress.
• Capital Bone Density (Share Capital): Exceptionally high. The issued share capital stands at £20,333,333. For a private limited company in the non-life insurance sector, this represents a formidable structural foundation, suggesting the business is heavily capitalised—either to fund significant operations, meet regulatory capital requirements, or as a result of corporate restructuring.
• Corporate DNA (Ownership & Control): Subsidiary status. The PSC (Person with Significant Control) is "Qmetric Group Holdings Limited." This means our patient is part of a wider corporate anatomy. The financial health of the parent entity will have a direct contagion effect on this company.
• Neurological Health (Directorate): Recently altered. We observe recent changes in the board. Kevin David Chidwick resigned as secretary and director in early/mid-2026, with Paul Simon Gildersleves stepping in as a replacement. While not necessarily a symptom of illness, sudden changes in key organ functions warrant monitoring to ensure strategic continuity.
• Industry Immune Environment (SIC Code 65120): Highly regulated. Operating in "Non-life insurance" means the company requires robust regulatory immunity to withstand FCA/PRA compliance demands and market volatility.

3. Diagnosis

The patient, QMETRIC GROUP LIMITED, is an active, well-capitalised subsidiary operating in the non-life insurance space.

The most prominent symptom in the clinical profile is the £20.3 million share capital. In the insurance sector, this is a healthy sign—insurance entities require substantial capital reserves to underwrite risk and satisfy regulatory solvency requirements. However, share capital alone is akin to a patient having a large reserve of stored energy; it does not tell us if the patient is currently burning more calories than they are consuming. Without the P&L reserve, net current assets, and cash flow data, we cannot diagnose whether the company is operating profitably or running at a loss that is being subsidised by this massive capital injection.

The company’s previous name change (from PGUK HAB 2 LIMITED shortly after incorporation in 2010) and the current holding company structure suggest this entity may have been formed as a special purpose vehicle or has undergone significant corporate surgery (restructuring) in its past, which is common in the insurance sector.

The recent transitions in the company secretariat and directorship are minor symptoms. While the patient is not in administrative or liquidation distress, any time there is a changing of the guard, there is a risk of temporary operational myopia.

4. Recommendations

To move from a provisional B+ to a clean bill of health, the following preventative and diagnostic measures are recommended:

• Complete the Blood Work: The most critical next step is to review the full filed accounts (Profit & Loss, Balance Sheet, and Cash Flow). You must verify that the £20.3M capital is being actively and efficiently deployed, rather than sitting idle or being eroded by operational losses.
• Monitor Liquidity Blood Pressure: Given the nature of non-life insurance, where claims can arise suddenly, it is vital to ensure that Current Assets comfortably exceed Current Liabilities. A healthy working capital ratio is the best defence against sudden financial haemorrhaging.
• Review Holding Company Contagion Risk: Because QMETRIC GROUP LIMITED is controlled by Qmetric Group Holdings Limited, stakeholders should assess the parent company's financial wellness. Financial distress at the holding company level can easily drain the capital reserves of a healthy subsidiary through dividend extractions or inter-company loans.
• Ensure Regulatory Fitness: With recent changes in the boardroom (the appointment of new directors and a secretary), ensure that the new leadership maintains strict compliance with FCA/PRA solvency and conduct standards to avoid regulatory penalties.